Cavitation Technologies Inc (CVAT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CVAT Annual Balance Sheets →
This balance sheet overview for Cavitation Technologies Inc spans from Mar 31 2025 to Mar 31 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent0.05
Cash & Short-term Investments0.00
Accounts receivable0.00
Prepaid Expense, Current AS0.01
Total Current Assets0.06
Long-term investments0.00
Other Assets, Noncurrent0.01
Total Assets0.07
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.25
Derivative Liability, Current DE0.02
Convertible Notes Payable, Current NO0.03
Total Current Liabilities0.38
Long-term debt0.15
Total Long-term Debt0.15
Other liabilities, Noncurrent0.09
Note Payable Related Party0.09
Total Liabilities0.53
Stockholders' Equity
Common Stock Value0.31
Additional Paid In Capital Common Stock27.14
Retained Earnings / Accumulated Deficit-27.91
Other Equity0.00
Common Stockholder's Equity-0.47
Total Stockholder's Equity-0.47
Liabilities & Stockholder's Equity0.07
4 historic quarters locked

Sign in to unlock the full Cavitation Technologies Inc balance sheet history.

About Cavitation Technologies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-004131

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.